USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Alcohol Dependence and Abuse Pharmaceuticals Market - Therapeutic Overview and Patient Outlook
U.S. Alcohol Dependence and Abuse Pharmaceuticals Market - Therapeutic Overview and Patient Outlook
RELEASE DATE
22-Jan-2008
22-Jan-2008
REGION
North America
North America
Research Code: N30B-01-00-00-00
SKU: HC02061-NA-MR_07454
$4,950.00
In stock
SKU
HC02061-NA-MR_07454
Description
This research service covers the U.S. alcohol dependence and abuse pharmaceuticals market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product as follows: Antabuse, Campral, ReVia, and Vivitrol. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.
Table of Contents
Executive Summary
- Introduction
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Disease Overview
- Introduction
- Disease Definition
- Signs and Symptoms
- Risk Factors
- Diagnosis
- Treatment
- Health Risks of Excessive Alcohol Consumption
- Disease Statistics
Patient Outlook
- Patient Forecasts
General Market Trends
- Industry Challenges
- Market Drivers
- Market Restraints
Popular Topics
This research service covers the U.S. alcohol dependence and abuse pharmaceuticals market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product as follows: Antabuse, Campral, ReVia, and Vivitrol. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | N30B-01-00-00-00 |
| Is Prebook | No |